CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balances (in shares) at Dec. 31, 2021		44,640,000
Balances at Dec. 31, 2021	$ 102,414	$ 4	$ 531,636	$ (429,226)
Increase (Decrease) in Stockholders' Equity
Common stock issuance and other impacts of the vesting and settlement of equity awards (in shares)		705,000
Common stock issuance and other impacts of the vesting and settlement of equity awards	(707)		(707)
Issuance of common stock in connection with at-the-market program (in shares)		2,464,000
Issuance of common stock in connection with at-the-market program	7,020	$ 1	7,019
Issuance of common stock upon exercise of warrant (in shares)		388,000
Stock-based compensation	5,116		5,116
Net loss and comprehensive loss	21,072			21,072
Net income and comprehensive income	21,072			21,072
Balances (in shares) at Sep. 30, 2022		48,197,000
Balances at Sep. 30, 2022	134,915	$ 5	543,064	(408,154)
Balances (in shares) at Jun. 30, 2022		48,172,000
Balances at Jun. 30, 2022	128,369	$ 5	540,692	(412,328)
Increase (Decrease) in Stockholders' Equity
Common stock issuance and other impacts of the vesting and settlement of equity awards (in shares)		25,000
Common stock issuance and other impacts of the vesting and settlement of equity awards	(28)		(28)
Stock-based compensation	2,400		2,400
Net loss and comprehensive loss	4,174			4,174
Net income and comprehensive income	4,174
Balances (in shares) at Sep. 30, 2022		48,197,000
Balances at Sep. 30, 2022	$ 134,915	$ 5	543,064	(408,154)
Balances (in shares) at Dec. 31, 2022	48,319,838	48,320,000
Balances at Dec. 31, 2022	$ 225,725	$ 5	545,321	(319,601)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of options (in shares)		133,000
Issuance of common stock upon exercise of options	210		210
Common stock issuance and other impacts of the vesting and settlement of equity awards (in shares)		1,102,000
Common stock issuance and other impacts of the vesting and settlement of equity awards	(7,980)		(7,980)
Induced exchange of convertible notes (in shares)		6,990,000
Induced exchange of convertible notes	26,699		26,699
Issuance of common stock in connection with the Spectrum Merger, net of fractional share settlement (in shares)		38,008,000
Issuance of common stock in connection with the Spectrum Merger, net of fractional share settlement	216,261	$ 4	216,257
Stock-based compensation	6,516		6,516
Net loss and comprehensive loss	(274,558)			(274,558)
Net income and comprehensive income	$ (274,558)			(274,558)
Balances (in shares) at Sep. 30, 2023	94,553,009	94,553,000
Balances at Sep. 30, 2023	$ 192,873	$ 9	787,023	(594,159)
Balances (in shares) at Jun. 30, 2023		56,513,000
Balances at Jun. 30, 2023	254,271	$ 5	568,881	(314,615)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of options (in shares)		23,000
Issuance of common stock upon exercise of options	54		54
Common stock issuance and other impacts of the vesting and settlement of equity awards (in shares)		9,000
Common stock issuance and other impacts of the vesting and settlement of equity awards	(33)		(33)
Issuance of common stock in connection with the Spectrum Merger, net of fractional share settlement (in shares)		38,008,000
Issuance of common stock in connection with the Spectrum Merger, net of fractional share settlement	216,261	$ 4	216,257
Stock-based compensation	1,864		1,864
Net loss and comprehensive loss	(279,544)			(279,544)
Net income and comprehensive income	$ (279,544)			(279,544)
Balances (in shares) at Sep. 30, 2023	94,553,009	94,553,000
Balances at Sep. 30, 2023	$ 192,873	$ 9	$ 787,023	$ (594,159)